文献速递前列腺癌

基线前列腺萎缩与重复活检前列腺癌肿瘤体积较低相关

Baseline prostate atrophy is associated with lower tumor volume in men with prostate cancer on repeat biopsy.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2017-12-04

该回顾性分析纳入927名50-75岁基线活检阴性、2年或4年重复活检阳性的男性,评估基线前列腺萎缩(PA)与重复活检时肿瘤体积的关系。PA见于60%基线活检,与更大的前列腺体积相关(P<0.001);2年活检时PA与较低的总肿瘤体积(2.21 vs 2.94 µL;P=0.016)及较低活检阳性针数比例等相关。结论提示PA可能与侵袭性较低的前列腺癌相关。

要点

  • 基线PA见于60%活检,其中轻度88%、中/重度12%。
  • 2年活检时PA组总肿瘤体积2.21 vs 2.94 µL(P=0.016)。
  • 中/重度PA较轻度的肿瘤体积降低幅度更大。

核心结论

  • 在基线活检阴性、重复活检阳性的男性中,基线PA的存在及严重程度与较低的PCa体积相关,提示PA可能与侵袭性较低的PCa相关。

研究设计与样本

  • 对Reduction by Dutasteride of PCa Events研究中927名50-75岁、基线活检阴性且2年或4年重复活检阳性的男性进行回顾性分析。
  • PA(存在/不存在)、PA严重程度(轻度/中重度)及肿瘤体积由中心病理确定。
  • 采用线性回归和Poisson回归进行单变量和多变量分析评估基线PA与重复活检PCa体积的关联。

主要发现

  • PA见于559例(60%)基线活检,其中轻度491例(88%)、中/重度68例(12%)。
  • PA与更大的前列腺体积相关(P<0.001)。
  • 2年活检时,PA与较低的总平均肿瘤体积(2.21 vs 2.94 µL;P=0.016)、平均活检阳性针数(1.85 vs 2.08;P=0.016)、平均阳性针数百分比(18.4% vs 20.7%;P=0.008)、平均单针肿瘤体积(0.23 vs 0.29 µL;P=0.019)及总体平均肿瘤累及百分比(1.82% vs 2.33%;P=0.018)相关。
  • 多变量分析及4年重复活检分析结果相似。
  • 与轻度PA相比,中/重度PA与肿瘤体积降低幅度更大相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prostate atrophy (PA) is commonly identified in prostate biopsies. Previous studies suggest PA may be associated with lower PCa risk. However, it remains unclear whether PA is associated with smaller, less aggressive, and less advanced tumors. Thus, we sought to determine whether the presence and severity of baseline PA in men with initial biopsy negative for prostate cancer (PCa) is associated with PCa volume at 2- and 4-year repeat biopsy. METHODS: We performed a retrospective analysis of 927 men 50-75-years-old with negative baseline biopsy and positive 2- or 4-year repeat biopsy for PCa in the Reduction by Dutasteride of PCa Events study. PA (present or absent), PA severity (mild or moderate/marked), and tumor volume were determined by central pathology. The association of baseline PA with repeat biopsy PCa volume was evaluated with linear and Poisson regressions in uni- and multivariable analyses. RESULTS: PA was identified in 559 (60%) baseline biopsies and was mild in 491 (88%) and moderate/marked in 68 (12%). PA was associated with larger prostate volumes (P < 0.001). At 2-year biopsy, PA was associated with lower overall mean total tumor volume (2.21 vs. 2.94 µL; P = 0.016), mean number of biopsy cores involved (1.85 vs. 2.08; P = 0.016), mean percent of cores involved (18.4% vs. 20.7%; P = 0.008), average core involvement (0.23 vs. 0.29 µL; P = 0.019) and overall mean percent tumor involvement (1.82% vs. 2.33%; P = 0.018). Similar results were found in multivariable analysis and analysis of 4-year repeat biopsies. Compared to mild PA, moderate/marked PA was associated with greater reduction in tumor volume. CONCLUSION: Amongst subjects with repeat prostate biopsy positive for PCa after negative baseline biopsy, the presence and severity of baseline PA were associated with lower PCa volume. This suggests PA may be associated with less aggressive PCa.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Moreira DM, Andriole GL, Castro-Santamaria R, et al. Baseline prostate atrophy is associated with lower tumor volume in men with prostate cancer on repeat biopsy. Prostate Cancer Prostatic Dis. 2017. PMID: 29203895. doi:10.1038/s41391-017-0012-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。